To increase transparency, India’s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price. Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has...
More »SEARCH RESULT
Antibiotic challenges, dilemmas, policies by KS Jacob
India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....
More »Highest operational SEZs in southern India
South India is way ahead of other regions in encashing on the tax-free special economic zones scheme as 79 of 130 functional SEZs are located in four southern states. Among southern states, Andhra Pradesh is on the top of the table with a maximum number of 32 operational special economic zones (SEZs) followed by Tamil Nadu (22), Karnataka (20) and Kerala (7), according to the latest government data. The sector-wise data shows...
More »Patients rally against trade pact with EU
Patients battling cancer, infections and mental illness joined a rally here today beseeching the government to reject a trade pact with the European Union that they fear will threaten the availability of inexpensive generic medicines in India. An estimated 2,000 people, many among them infected with HIV, walked along Delhi’s Parliament Street on a day when Indian and EU officials were negotiating a free trade agreement in Brussels. Health activists and lawyers...
More »India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India–EU Free Trade Agreement (FTA) negotiations. For instance, EU negotiators have sought India’s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate...
More »